Dr Julie Vose on the Importance of Attending PCOC15

Julie Vose, MD, MBA, FASCO, president of the American Society of Clinical Oncology and keynote speaker at Patient-Centered Oncology Care 2015, explains the importance of the meeting and how patients benefit when a diverse set of stakeholders come together in one room.

Transcript (slightly modified for readability)

The American Journal of Managed Care's Patient-Centered Oncology meeting brings together a mix of healthcare stakeholders—what impact does this meeting have on healthcare?

These types of meetings are really important. A lot of times we stay in our individual little silos and don't get together and talk, so having all the stakeholders together who are involved in this process, such as with this meeting, I think will be very important. To try to get everybody in one room, have a discussion, talk about the individual situations, and how can we try to come to a solution to all work together to improve cancer care and to make it a value proposition for the patient.

How do patients benefit when such a diverse set of stakeholders gets together at a meeting like Patient-Centered Oncology Care?

I think a lot of times the physicians don't know what some of the drugs cost or the treatments cost, so trying to make sure we get everyone together in the same room and try to understand the information and to make sure everyone is collaborating and discussing things together is very important. So whenever we do that the patient is the one who benefits because we can clarify this and be sure we're using the research in the right way and get the information to the patient, what is most valuable to that individual patient.

See the full agenda and register now to save your seat: www.ajmc.com/meetings/pcoc15